| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | imiquimod (Aldara®) |
| Formulation | 5% cream |
| Reference number | 164 |
| Indication | Topical treatment of external genital and perianal warts and small superficial basal cell carcinomas in adult patients |
| Company | Meda Pharmaceuticals Ltd |
| BNF chapter | Skin |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 10/08/2004 |